Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers

Clinical Lung Cancer

Volumn 14, Issue 5, 2013, Pages 513-520

  Katseli, Anastasia ^a   Maragos, Haralampos ^b   Nezos, Adrianos ^a   Syrigos, Konstantinos ^b   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Keratin 19; Lung specific X protein; Multiplex PCR; Parathyroid hormone related protein; Peripheral blood

Indexed keywords

CYTOKERATIN 19; LUNG SPECIFIC X PROTEIN; MESSENGER RNA; MOLECULAR MARKER; PARATHYROID HORMONE RELATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PATIENT MONITORING; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

KERATIN 19; LUNG-SPECIFIC X PROTEIN; MULTIPLEX PCR; PARATHYROID HORMONE-RELATED PROTEIN; PERIPHERAL BLOOD;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PARATHYROID HORMONE-RELATED PROTEIN; PHOSPHOPROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84883775734     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.04.007     Document Type: Article

References (50)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Web site]. Available at: http://globocan.iarc.fr. Accessed: November 10, 2012.
2. B.E. Lee, J.L. Port, and B.M. Stiles TNM stage is the most important determinant of survival in metachronous lung cancer Ann Thorac Surg 88 2009 1100 1105
3. T.G. Lugo, S. Braun, and R.J. Cote Detection and measurement of occult disease for the prognosis of solid tumors J Clin Oncol 21 2003 2609 2615
4. J. Lacroix, and M.K. Doeberitz Technical aspects of minimal residual disease detection in carcinoma patients Semin Surg Oncol 20 2001 252 264
5. K. Pantel, and R.H. Brakenhoff Dissecting the metastatic cascade Nat Rev Cancer 4 2004 448 456
6. A. Nezos, P. Lembessis, and A. Sourla Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance Clin Chem Lab Med 47 2009 1 11
7. A. Armakolas, Z. Panteleakou, and A. Nezos Detection of the circulating tumor cells in cancer patients Future Oncol 6 2010 1849 1856
8. D.F. Hayes, and J.B. Smerage Circulating tumor cells Prog Mol Biol Transl Sci 95 2010 95 112
9. A.E. Hoeppener, J.F. Swennenhuis, and L.W. Terstappen Immunomagnetic separation technologies Recent Results Cancer Res 195 2012 43 58
10. K. Isobe, Y. Hata, and K. Kobayashi Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer Anticancer Res 32 2012 3339 3344
11. T. Naito, F. Tanaka, and A. Ono Prognostic impact of circulating tumor cells in patients with small cell lung cancer J Thorac Oncol 7 2012 512 519
12. P. Mordant, Y. Loriot, and B. Lahon Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells PLoS One 6 2011 e26073
13. Y. Okumura, F. Tanaka, and K. Yoneda Circulating tumor cells in pulmonary venous blood of primary lung cancer patients Ann Thorac Surg 87 2009 1669 1675
14. Z. Panteleakou, P. Lembessis, and A. Sourla Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance Mol Med 15 2009 101 114
15. A. Nezos, N. Pissimisis, and P. Lembessis Detection of circulating tumor cells in bladder cancer patients Cancer Treat Rev 35 2009 272 279
16. A. Tsouma, C. Aggeli, and N. Pissimissis Circulating tumor cells in colorectal cancer: detection methods and clinical significance Anticancer Res 28 2008 3945 3960
17. A. Nezos, P. Msaouel, and N. Pissimissis Methods of detection of circulating melanoma cells: a comparative overview Cancer Treat Rev 37 2011 284 290
18. A. Tsouma, C. Aggeli, and P. Lembessis Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients World J Gastroenterol 16 2010 5965 5974
19. P. Msaouel, and M. Koutsilieris Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis BMC Cancer 11 2011 336
20. F. Le Pimpec-Barthes, C. Danel, and R. Lacave Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence Eur J Cancer 41 2005 306 312
21. L. Liu, G.Q. Liao, and P. He Detection of circulating cancer cells in lung cancer patients with a panel of marker genes Biochem Biophys Res Commun 372 2008 756 760
22. K. Peck, Y.P. Sher, and J.Y. Shih Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients Cancer Res 58 1998 2761 2765
23. C.S. Mitsiades, P. Lembessis, and A. Sourla Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer Clin Exp Metastasis 21 2004 495 505
24. C.F. Mountain, and C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
25. N. Martini, M.S. Bains, and M.E. Burt Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
26. K. Pantel, R.J. Cote, and O. Fodstad Detection and clinical importance of micrometastatic disease J Natl Cancer Inst 91 1999 1113 1124
27. L.A. Devriese, A.J. Bosma, and M.M. van de Heuvel Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis Lung Cancer 75 2011 242 247
28. T.F. Chen, G.L. Jiang, and X.L. Fu CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor Lung Cancer 56 2007 105 114
29. C.C. Sheu, M.Y. Chang, and H.C. Chang Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer Oncology 70 2006 203 211
30. S.A. Burchill, M.F. Bradbury, and K. Pittman Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction Br J Cancer 71 1995 278 281
31. M. Ge, D. Shi, and Q. Wu Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy J Cancer Res Ther 1 2005 221 226
32. M.J. Ge, Q.C. Wu, and M. Wang Detection of circulating tumor cells (CTCs) in patients lung carcinoma by real-time fluorescent quantitative-approach before and after chemotherapy Health 1 2009 231 238
33. Y. Ko, E. Grünewald, and G. Totzke High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis of illegitimate gene expression Oncology 59 2000 81 88
34. G. Castaldo, R. Tomaiuolo, and A. Sanduzzi Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Eur Respir J 22 2003 418 421
35. A.M. Dingemans, R.H. Brakenhoff, and P.E. Postmus Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients Lab Invest 77 1997 213 220
36. P. Ruud, O. Fodstad, and E. Hovig Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells Int J Cancer 80 1999 119 125
37. J.A. López-Guerrero, P. Bolufer-Gilabert, and M. Sanz-Alonso Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR) Clin Chim Acta 263 1997 105 116
38. A. Zippelius, P. Kufer, and G. Honold Limitations of reverse- transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow J Clin Oncol 15 1997 2701 2708
39. F. You, L.A. Roberts, and S.P. Kang Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells J Hematol Oncol 1 2008 2
40. R.H. Hastings, A.M. Laux, and A. Casillas Sex-specific survival advantage with PTHrP in non-small cell lung carcinoma patients Clin Cancer Res 12 2006 499 506
41. G.G. Wulf, B. Jürgens, and T. Liersch Reverse transcriptase/ polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer J Cancer Res Clin Oncol 123 1997 514 521
42. L. Xi, D.G. Nicastri, and T. El-Hefnawy Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers Clin Chem 53 2007 1206 1215
43. S.A. Rabbani, J. Gladu, and P. Harakidas Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo Int J Cancer 80 1999 257 264
44. F. Asadi, M. Farraj, and R. Sharifi Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia Hum Pathol 27 1996 1319 1323
45. H. Yamato, Y. Nagai, and D. Inoue In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer J Bone Miner Res 10 1995 36 44
46. L.J. Deftos, I. Barken, and D.W. Burton Direct evidence that PTHrP expression promotes prostate cancer progression in bone Biochem Biophys Res Comm 327 2005 468 472
47. K. Iwao, T. Watanabe, and Y. Fujiwara Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer Int J Cancer 91 2001 433 437
48. G.Y. Zhu, D.L. Liu, and M.Q. Peng Detection of micrometastases of lung cancer by using lunx mRNA specific reverse transcription-polymerase chain reaction Chin J Cancer Res 14 2002 54 59
49. M. Mitas, L. Hoover, and G. Silvestri Lunx is a superior: molecular marker for detection of non-small lung cell cancer in peripheral blood J Mol Diagn 5 2003 237 242
50. M. Cheng, Y. Chen, and X. Yu Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer BMC Cancer 8 2008 156